PRAME Immunoexpression in 275 Cutaneous Melanocytic Lesions: A Double Institutional Experience
Sign Up to like & getrecommendations! Published in 2022 at "Diagnostics"
DOI: 10.3390/diagnostics12092197
Abstract: In recent years, the preferentially expressed antigen in melanoma (PRAME) has also been used in the histopathological diagnosis of melanocytic lesions, in order to understand if it could constitute a valid, inexpensive, and useful resource… read more here.
Keywords: prame; melanocytic lesions; potential malignancy; immunoexpression ... See more keywords